z-logo
open-access-imgOpen Access
P2Y12 inhibitors: do they increase cancer risk?
Author(s) -
Joseph J. Fierro,
Brandon Cave,
Rami N. Khouzam
Publication year - 2019
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2019.07.90
Subject(s) - medicine , p2y12 , aspirin , timi , ticagrelor , prasugrel , acute coronary syndrome , coronary artery disease , cancer , intensive care medicine , clopidogrel , oncology , conventional pci , myocardial infarction

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom